Related Experiment Video

Updated: Jul 23, 2025

On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.0K

Inflammation and cholesterol at the crossroads of vascular risk

Subodh Verma1, C David Mazer2, Kim A Connelly3

  • 1Division of Cardiac Surgery, Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute, St Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Departments of Surgery, and Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.

Cell Metabolism
|July 12, 2023
PubMed

Insights

Residual inflammatory risk, not just cholesterol, predicts cardiovascular events even after treatment. Inflammation testing may guide future vascular risk reduction strategies for better patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Lipidology

Background:

  • The role of inflammation in atherosclerosis is well-established.
  • The significance of inflammation after low-density lipoprotein cholesterol (LDL-C) lowering remains uncertain.
  • Residual risk after LDL-C treatment presents a clinical challenge.

Purpose of the Study:

  • To evaluate the predictive value of residual inflammatory risk versus residual cholesterol risk.
  • To determine if inflammation testing can guide vascular risk reduction.

Main Methods:

  • Analysis of data from a study published in The Lancet.
  • Comparison of the predictive power of inflammatory markers and cholesterol levels.
  • Assessment of fatal and non-fatal cardiovascular events.

Main Results:

  • Residual inflammatory risk was a stronger predictor of cardiovascular events than residual cholesterol risk.
  • Inflammation testing demonstrated significant predictive value for vascular events.
  • Findings support the clinical utility of assessing inflammation in high-risk patients.

Conclusions:

  • Inflammation remains a critical factor in atherosclerosis progression, even after effective LDL-C reduction.
  • Inflammation testing can identify individuals at higher residual risk.
  • Targeting residual inflammatory risk may enhance vascular risk reduction strategies.

More Related Videos

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

13.4K
Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly00:06

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

15.4K

Related Concept Videos

Inflammation01:38

Inflammation

Overview
53.9K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
592
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
54
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
13